Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.
von Bueren, A O
Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91. [electronic resource] - Klinische Padiatrie - 396-7 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1439-3824
10.1055/s-0029-1238278 doi
Adolescent
Age Factors
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cerebellar Neoplasms--drug therapy
Child
Child, Preschool
Cisplatin--administration & dosage
Combined Modality Therapy
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Humans
Lomustine--administration & dosage
Male
Medulloblastoma--drug therapy
Neoadjuvant Therapy
Nervous System Diseases--chemically induced
Prospective Studies
Radiotherapy, Adjuvant
Risk Factors
Vincristine--administration & dosage
Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91. [electronic resource] - Klinische Padiatrie - 396-7 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1439-3824
10.1055/s-0029-1238278 doi
Adolescent
Age Factors
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cerebellar Neoplasms--drug therapy
Child
Child, Preschool
Cisplatin--administration & dosage
Combined Modality Therapy
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Humans
Lomustine--administration & dosage
Male
Medulloblastoma--drug therapy
Neoadjuvant Therapy
Nervous System Diseases--chemically induced
Prospective Studies
Radiotherapy, Adjuvant
Risk Factors
Vincristine--administration & dosage